Onxeo Announces Its Financial Calendar for 2017

Paris (France), Copenhagen (Denmark) Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO), a biopharmaceutical company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, today announced its financial calendar for 2017:

March 7, 2017                                      Full-year 2016 consolidated accounts 

April 26, 2017                                      General shareholders’ meeting (to be convened in Paris)

April 27, 2017                                      Quarterly information as of March 31, 2017

July 28, 2017                                        Consolidated accounts for the 1st half of 2017

October 26, 2017                                Quarterly information as of September 30, 2017

This financial calendar is for indicative purposes only and Onxeo could change its publication dates should it deem it necessary.

Download PDF